Filter By Industry
Filter By Tag

Newsroom

E-QURE Corp Press releases

1 - 3 of 3 Press Releases

FDA granted E-QURE approval to initiate its US clinical trial
Nov 03, 2016
Delaware, USA, August 3, 2015 - E-QURE Corp. (OTC QB, EQUR), a Delaware corporation engaged in the commercialization of its Bio-electrical Signal Therapy device ("BST Device"), a new and novel electrotherapy for the non-invasive treatment of hard-to-heal.

Dr. Michael Sessler joined E-QURE board of directors
Apr 11, 2015
Dr. Sessler, is an MD that has gained proficiency and 20 years experience in business development and marketing.

E-QURE has established a Scientific Advisory Board appointing Dr. Ben-Zion Weiner and Prof. Avi Ohry
Sep 17, 2014
The Wound Healing Medical Device company nominated two prominent, well experienced scientists, to guide the company in its coming clinical trial and industry recognition.


E-QURE Corp RSS Feed